Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Bayer Enters $658 Million Deal to Market Hua's Diabetes Drug in China

publication date: Aug 18, 2020

Hua Medicine put Bayer AG in charge of China commercialization of its lead program -- dorzagliatin, a novel treatment for type 2 diabetes. Hua will receive $58 million upfront and up to $600 million in milestones. In China, Bayer is a major player in the diabetes market because of Glucobay®, its generic oral treatment for type 2 diabetes. Hua Medicine will continue to be responsible for clinical development, registration, product supply and distribution, while Bayer will take over marketing, promotion and medical education. More details....

Stock Symbols: (HK: 2552) (Xetra: BAYN)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here